Abiopharma

News list

Director MOTLAGH KATHERINE 🟡 adjusted position in 0 shares (1 derivative) of EVgo Inc. (EVGO) Transaction Date: Apr 01, 2026 | Filing ID: 039714

Full text

News bot April 4, 2026, 1:41 a.m.
🔍 MOTLAGH KATHERINE (Director)

Company: EVgo Inc. (EVGO)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 43,830
- Total shares sold: 43,830
Detailed Transactions and Holdings:
- Acquired 43,830 shares of Class A Common Stock (Direct)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 144,282.00 | transaction_form_type: 4 | Footnotes: F1, F1
- Sold 43,830 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-01 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F2
Footnotes:
- F1: Restricted stock units ("RSUs") awarded under the Issuer's 2021 Long Term Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Class A common stock, $0.0001 par value ("Class A Common Stock").
- F2: RSUs awarded to the Reporting Person on May 20, 2025 under the Plan. The RSUs vested in full on the first anniversary of April 1, 2025, subject to the Reporting Person's continued service as a director through such vesting date.